Could a simple stool test revolutionize TB diagnosis for kids and HIV patients?
NCT ID NCT05047315
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study evaluated a new stool-based test (qPCR) to diagnose tuberculosis (TB) in children under 8 and people living with HIV. Researchers in Mozambique, Eswatini, and Uganda tested nearly 2,000 participants to see if the stool test could improve TB detection rates compared to standard methods like sputum tests. The goal is to make TB diagnosis easier and more accessible for those who are often missed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- stool-based qPCR diagnostic test
- What this could lead to
- If successful, this could provide a simpler, non-invasive way to diagnose tuberculosis in hard-to-test groups like children and people with HIV, potentially increasing detection rates.
- What could go wrong
- This is a completed diagnostic accuracy study, not a treatment trial. The test may not be accurate enough in real-world settings, and it does not directly improve health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIAGNOSES DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor Eswatini Clinical Centre of Excellence (COE)
Mbabane, Eswatini
-
Centro de investigação de Saúde de Manhiça
Manhiça, Maputo Province, 1929, Mozambique
-
Makerere University
Kampala, Uganda
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new patient cohort unlock the secrets of TB treatment success?
- Shorter TB treatment: a 4-Month regimen put to the test
- Can immune profiling unlock the hidden stages of tuberculosis?
- Lung damage after TB: a new study tests whether rehabilitation can restore breathing and quality of life
- Marathon runners and heart patients put a new troponin test to the ultimate challenge
- Can a more powerful antibiotic clear TB faster? a trial puts rifapentine to the test.